Your browser doesn't support javascript.
loading
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.
Batchelor, Tracy T; Mulholland, Paul; Neyns, Bart; Nabors, L Burt; Campone, Mario; Wick, Antje; Mason, Warren; Mikkelsen, Tom; Phuphanich, Surasak; Ashby, Lynn S; Degroot, John; Gattamaneni, Rao; Cher, Lawrence; Rosenthal, Mark; Payer, Franz; Jürgensmeier, Juliane M; Jain, Rakesh K; Sorensen, A Gregory; Xu, John; Liu, Qi; van den Bent, Martin.
Afiliação
  • Batchelor TT; Tracy T. Batchelor, Rakesh K. Jain, and Gregory Sorensen, Massachusetts General Hospital, Boston, MA; Paul Mulholland, University College London, London; Rao Gattamaneni, the Christie Foundation Trust Hospital, Manchester, United Kingdom; Bart Neyns, Universitair Ziekenhuis Brussel, Brussels, Belgium; L. Burt Nabors, University of Alabama at Birmingham, Birmingham, AL; Mario Campone, Centre Rene Gauducheau, Saint-Herblain, France; Antje Wick, University of Heidelberg, Heidelberg, Germany; Warren
J Clin Oncol ; 31(26): 3212-8, 2013 Sep 10.
Article em En | MEDLINE | ID: mdl-23940216

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2013 Tipo de documento: Article